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Abstract
Background: It has previously been hypothesized that lower socio-economic status can accelerate biological ageing, and
predispose to early onset of disease. This study investigated the association of socio-economic and lifestyle factors, as well
as traditional and novel risk factors, with biological-ageing, as measured by telomere length, in a Glasgow based cohort that
included individuals with extreme socio-economic differences.
Methods: A total of 382 blood samples from the pSoBid study were available for telomere analysis. For each participant,
data was available for socio-economic status factors, biochemical parameters and dietary intake. Statistical analyses were
undertaken to investigate the association between telomere lengths and these aforementioned parameters.
Results: The rate of age-related telomere attrition was significantly associated with low relative income, housing tenure and
poor diet. Notably, telomere length was positively associated with LDL and total cholesterol levels, but inversely correlated
to circulating IL-6.
Conclusions: These data suggest lower socio-economic status and poor diet are relevant to accelerated biological ageing.
They also suggest potential associations between elevated circulating IL-6, a measure known to predict cardiovascular
disease and diabetes with biological ageing. These observations require further study to tease out potential mechanistic
links.
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Introduction
Gompertz (1825) first described ageing as an increase in the
likelihood of mortality with increasing chronological age [1]. In
man, this equates to a corresponding, progressive loss of metabolic
and physiological functions, though the trajectory for this is not
uniform, indicative of underlying inter-individual variation in the
biology of ageing [2].
Variation in the rate of biological ageing reflects the cumula-
tive burden of genetic, metabolic and environmental stressors,
resulting in oxidative damage and elevated inflammatory processes
[3]. This is of particular interest in Glasgow, because of the
exceptional gradient of socio-economic status (SES) in this city and
the associated variation in mortality and morbidity. The latter is
reflected in the large difference in life expectancy for men,
between the most and least deprived areas of the city, which is 28.7
years [4]; a difference which is one of the largest in the developed
world. We investigated potential mechanisms for such gradients as
part of the psychological, social, and biological determinants of ill
health (pSoBid) study cohort [5], the characteristics of which have
been described in depth elsewhere [6]. Briefly, the pSoBid study
was designed to investigate the factors linking social circumstances,
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were selected from the least and most deprived areas in the NHS
Greater Glasgow Health Board area. We have hypothesised that
such a difference in life expectancy might be reflected in the
biological age of individuals. In turn we considered whether
deprivation-related measures correlated to accelerated telomere
attrition and also determined interactions with inflammatory status.
Suitable and validated biomarkers for analysing biological
ageing in this context are limited in number. Despite cell cycle
inhibitor transcript levels providing an accurate indication of
organ and T cell biological age [7–9] the overwhelming majority
of studies employ determination of telomere length in peripheral
blood leukocytes (PBLs) in a clinical context [10–12]. However,
there are many equivocal reports regarding how useful this marker
is when applied in epidemiological studies [13,14].
Telomeres are nucleoprotein complexes at chromosome ends,
consisting of (TTAGGG)n direct repeats bound to a range of
proteins involved in maintaining cellular stability and viability
(reviewed in [3]). Typically, in larger mammals, the telomeric
DNA component shortens with successive cell divisions. This arises
from what has been termed the end replication problem [15].
Telomere attrition is thought to represent a molecular clock, at
least at the cellular level, where it has been hypothesised to act as
an anti-neoplastic mechanism [16], proposed to function by
countering the accumulation of mutations over successive cell
divisions, which potentially could produce neoplastic cells.
Although telomere length is inversely related to chronological
age in humans, there is considerable inter-individual variation in
telomere length at any specific age [17]. Thus estimates of the
effects of chronological age as a covariable in regression models
have relatively wide confidence intervals, making detection of
significant effects of age-related diseases more difficult: it may be
unclear how much of the residual variance is explained by the
disease and how much is attributable to error in the estimate of an
age effect. This has been discussed in detail eleswhere [18,19].
Recent human data have now established telomere attrition as a
major risk factor for numerous diseases, including cardiovascular
disease (CVD), hypertension, diabetes and end stage renal disease
[11,20–22] as well as being associated with elevated psychological
stresses [23]. Many such pathologies, showing an association with
increased telomere attrition rates, are predominant in deprived
communities where there is a higher prevalence of classical risk
factors for disease, but this explanation does not account totally for
these variations in disease incidence [10,24,25].
One hypothesis for the increased disease prevalence in these
communities is underlying chronic inflammation (elevated CRP or
IL-6), a known component and predictor of CVD and diabetes
[26,27], that is linked to a diverse range of pathologies. A possible
contributory factor to generating an increased pro-inflammatory
state, is accelerated biological ageing. Both telomere attrition and
CDKN2A expression have been reported to show association with
IL-6 levels in disease [11] and ostensibly ‘healthy’ populations [9].
Such associations are intuitive, as senescent cells upregulate
and secrete pro-inflammatory cytokines as part of the senescent
secretosome [28].
A link between accelerated biological ageing and socio-
economic status has previously been reported by some [29], but
not by others [30,31]. The reasons for this equivocacy remain to
be proven, but may be attributable to methodological differences
[13]. Any putative link, however, may be weak and open to
multiple confounders, such as parental telomere length and epi-
genetic effects [32].
We have chosen to evaluate the contribution of socio-economic
factors to biological age, as measured by telomere length, in the
extreme setting of the pSoBid cohort, to determine to what extent
this in turn affects risk factors for ill health.
Results
Socio-economic and lifestyle factors
Telomere lengths were determined in PBLs by Q-PCR for 382
individuals. The SES and lifestyle factors investigated are shown in
Table S1, as are the median telomere lengths within subgroups of
these factors, overall and by three age groups.
The relationship between age, gender and biological ageing was
investigated by estimating the percentage change in telomere
length associated with a decade increase in age and male gender.
Age was strongly negatively associated with telomere length, each
decade predicting a 4.8% decrease in telomere length (p=0.002).
No significant difference in telomere length was observed between
males and females. There was also no difference between affluent
and deprived groups either in telomere length or age-related
telomere attrition. All subsequent analyses were adjusted for age,
gender and deprivation.
Of the SES and lifestyle factors investigated, only cigarette
smoking was associated with an overall reduction in telomere
length (6.6% reduction, p=0.050). However, household income,
housing tenure, and diet score were associated with steeper age-
related decline in telomere length (Table 1). Faster rates of age-
related telomere attrition were observed in individuals with an
average income less than £25,000 (7.7% vs 0.6% reduction per
decade, p=0.024), a diet score among the lower 50% of scores
(7.7% vs 1.8%, p=0.05), and home tenants (8.7% vs 2.2%,
p=0.038). Figure 1 highlights differences in telomere attrition
with income, housing tenure and diet score.
We investigated the extent to which the associations between
telomere attrition and household income, housing tenure, and diet
score were independent by adjusting for these interactions. All
three interactions were attenuated to a similar degree and were no
longer significant, suggesting that these three interactions are cor-
related but no single factor is driving these interactions (Table S2).
Biomarkers
Associations between biomarkers investigated and telomere
length are reported in Table 2. Individuals with longer telomeres
had increased levels of total cholesterol (2.4% increase in total
cholesterol per one SD increase in log telomere length, p=0.027)
and LDL cholesterol (3.7%, p=0.027). Conversely, shorter
telomeres were associated with increased levels of IL-6 (7.2%
decrease in IL6 levels per one SD increase in log telomere length,
p=0.022, Table 2). Further analysis, adjusting for deprivation,
income, diet and smoking status, maintained the positive asso-
ciation between telomere length and cholesterol (p=0.033) and
LDL cholesterol (p=0.026). Interestingly, the significant associa-
tion between telomere length and IL-6 was weakened when
adjusted for these SES factors. Analyses were performed to es-
tablish which individual factors had an impact on IL-6 expression
(Table 3). The significant association between shorter telomeres
and higher levels of IL-6 was lost when analyses were adjusted for
age and gender, or for smoking status deprivation, income and diet
(Table 3).
Discussion
It has been hypothesized that socio-economic deprivation can
accelerate biological ageing, resulting in shorter telomeres in
deprived individuals in comparison to more affluent-aged matched
controls. Five previous studies examining this relationship report
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equivocacy between these reports is possibly due to methodolog-
ical differences, variations inherent in individual cohorts and in the
veracity of subject answers relating to SES data, such as income,
which may be confounded by undeclared income. The present
study has examined the relationship between biological ageing,
SES and disease in participants in Glasgow, a city with an extreme
socioeconomic gradient, with documented health issues associated
with social deprivation.
Interestingly, in the light of possible confounders relating to the
veracity of SES data, employment status (men who reported being
out of work) was reported to associate significantly with shorter
telomeres [34], in a large cross sectional study from an overlapping
demographic area (the WOSCOPS cohort). Surprisingly, despite
the prevalence of CVD in this cohort and its proven association
with SES, there were no other associations found with other
markers of SES (including educational attainment, employment
status, area-based deprivation and physical stature measured as a
proxy for early life social circumstances).
Our data are not incongrous with previous reports, as we
observed no associations with area based deprivation and
employment. However, we have demonstrated a direct link
between accelerated biological ageing, low income and poor diet.
Furthermore, we have observed a relationship with a measure of
adiposity, namely waist/hip ratio (Table 1), a predictive measure
for CVD and diabetes as well as all cause mortality in prospective
studies [35].
These observations are intuitive and in keeping with the
Marmot findings [36,37] who indicated that relative health
inequalities are associated with SES. It is reasonable to assume
that a low relative income means a decreased likelihood of being
able to afford a good quality diet, leading to an acceleration in
biological ageing. Poorer quality, fat and sugar rich diets, are
known to result in the production of more reactive oxygen species,
which directly cause DNA breaks that lead to gene malfunction,
telomere attrition and disease [38,39].
Notably, these observations indicating an interaction between
biological ageing and SES are reinforced by the finding that
telomere length, in the pSoBid cohort, associates positively with
LDL cholesterol levels, a strong and unambiguous causal risk
factor in CVD.
In our study, telomere attrition was associated with increasing
IL-6 levels, an emerging risk factor for CVD, which may predict
fatal events more strongly than non-fatal events [40]. The
association of IL-6 with biological age is in keeping with recent
observations indicating that senescent cells up-regulate and secrete
IL-6 [9,11]. It would be expected, as a consequence of increased
telomere attrition, that this group would have more senescent cells
present and thus higher IL-6 levels and have an elevated risk of a
range of conditions, if indeed IL-6 is causally related to CVD and
diabetes. The association between accelerated biological ageing
and increased IL-6 levels has been previously been reported to be
linked with disease [11], general health [9] and social deprivation
[41]. These observations are congruent with more extant
inflammatory conditions in the most deprived, a situation
exacerbated by increasing age.
Our findings suggest the unadjusted association between
telomere length and IL-6 is strong, and it is still marginally
significant with adjustment for age and gender. This association is
only partially weakened by further adjusting for smoking but
subsequent addition of deprivation, income and diet does not
appear to weaken the IL-6-telomere association further (Table 3).
In simple terms, these observations suggest that varying upstream
factors drive both telomere shortening and elevated IL-6 levels.
However, we cannot exclude the possibility that part of the
mechanism for elevated IL-6 is via telomere shortening. Future
studies need to explore this potential further, particularly as IL-6 is
attracting increasing interest in the diabetes and CVD arenas
[27,40].
Of the four previous studies in this field [29–31,34] only two
have indicated an association with SES. These comprised an
analysis of female twins, where non manual workers had longer
telomere lengths than manual workers [29]. However, in analyses
in which the authors used a more comprehensive range of SES
categories, no evidence of a relationship was observed with
biological age. The other, analysed Chinese men and indicated
men with higher self-rated socioeconomic status have shorter
telomeres [31]. This was postulated as possibly being mediated
Table 1. Highlights the percentage change in telomere length per decade that is associated with SES and lifestyle factors.
% change in telomere length (95% CI) per decade associated with
SES & lifestyle factor
SES & Lifestyle Factor
SES & Lifestyle Factor
Subgroup NO
SES & Lifestyle Factor
Subgroup YES
Differences between
subgroups (p-value)
Social class: Manual 23.7 (27.5, 0.3) p=0.066 26.2 (211.1, 21.1) p=0.019 0.437
Household income: , £25,000 20.6 (25.3, 4.2) p=0.796 27.7 (211.6, 23.6) p,0.001 0.024
Years of education: Lower 50% 21.3 (25.9, 3.5) p=0.577 27.2 (211.0, 23.2) p=0.001 0.062
Housing tenure: Tenant 22.2 (26.1, 1.8) p=0.274 28.7 (213.1, 24.0) p,0.001 0.038
Physical activity level: Inactive 26.0 (210.5, 21.3) p=0.013 23.6 (27.5, 0.6) p=0.092 0.426
Current cigarette smoker 24.8 (28.2, 21.3) p=0.008 27.4 (213.6, 20.8) p=0.028 0.482
Diet score: Lower 50% 21.8 (26.1, 2.6) p=0.417 27.7 (211.7, 23.6) p,0.001 0.050
Excessive alcohol (.14 [F] or
21 [M] U/week)
24.8 (28.0, 21.3) p=0.007 25.0 (211.6, 2.0) p=0.156 0.944
Obese (BMI .30 kg/m2) 24.1 (27.5, 20.4) p=0.029 27.2 (212.8, 21.2) p=0.019 0.371
Waist/Hip ratio: Upper 50% 22.2 (26.5, 2.2) p=0.319 27.6 (211.6, 23.4) p=0.001 0.081
Individuals with an income , £25,000, housing tenants and those with a lower diet score were shown to have faster rates of age-related telomere attrition than those
earning .£25,000, house owners and individuals with higher diet scores. All analyses were adjusted for age, gender and deprivation group.
doi:10.1371/journal.pone.0022521.t001
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of chronic disease. These authors also argue that there may be
significant cultural, ethnic and age-related differences in social
determinants of health.
The Q-PCR methodology employed in the present study
yielded similar telomere length data in keeping with other reports
[10,33,42] using the same methodology. Our observations must
also be viewed with reference to the fact that any differences
reflect that PBL telomere length is neither an absolute, nor
precise measure of biological ageing. The telomere lengths
measured are an average and reflect a range of lengths in cells. A
better measure may be an absolute marker of cellular growth
arrest, such as CDKN2A [7–9]. The use of such a marker would
avoid the potentially confounding effects of differences in telo-
mere length measurement methodology, that currently beset the
field [14].
The difference in observations using telomere length as a
marker of biological ageing, that have been reported by different
groups have been elegantly summarised by Nordfjall et al [39].
Our observations find consensus with those using a similar
methodology, when applied to age, BMI, smoking, insulin, trigly-
cerides and glucose. Our observations on the effect of smoking,
however, maybe limited by lack of detailed information on
smoking history.
Figure 1. Regression analysis plots that highlight household income, housing tenure, and diet score were associated with steeper
age-related decline in telomere length. Faster rates of age-related telomere attrition were observed in individuals with an average income less
than £25,000 (7.7% vs 0.6% reduction per decade, p=0.024, (A)), home tenants (8.7% vs 2.2%, p=0.038 (B)) and a diet score among the lower 50% of
scores (7.7% vs 1.8%, p=0.05 (C)).
doi:10.1371/journal.pone.0022521.g001
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cholesterol, though these have previously been reported to be
associated with telomere length in a disease setting [11], along with
IL6 [7,9]. These observations were also in keeping with
concomitant elevation of DNA damage (as measured by 8-0H
dG levels) in a specific disease cohort. However, our observations
are consistent with previous biochemical analysis of the pSoBid
cohort [5], which demonstrated that total cholesterol and LDL
were inversely associated with deprivation. This is congruent with
more extant inflammatory conditions in the most deprived, a
situation exacerbated by increasing age. It is thus also in keeping
with the observed elevation of IL-6 correlating with short
telomeres.
Our observations provide an intuitive link between proven
socio-economic drivers of disease [5,36,37] and a biological
phenomenon underlying any predisposition, or extant disease,
namely cellular ageing. The tendency of our data to show faster
ageing in those with lower socio-economic status, is indicative of
this and reflects ‘more miles on the clock’ for these individuals.
This study may be limited by its size and cross sectional nature.
Indeed, the social gradient in Glasgow is so extreme that a
‘survivor effect’ among the most deprived cannot be excluded.
This merits a larger, longitudinal study to look at the relative
impacts of further markers of SES and potential SE and lifestyle
interventions. Such interventions are not without precedence and
appear to show direct benefit to biological ageing. A recent
intervention study in men with prostate cancer, reported that
changing lifestyle, primarily via better diet and increased exercise
leads to increased telomerase activity and deceleration of telomere
attrition rate [43]. A similar result in the pSoBid cohort would be
expected to have significant health benefits.
In summary, we show convincingly that factors associated with
lower socio-economic status and poor diet are relevant to
accelerated biological ageing in a cohort representing extremes
of social class. Our findings also suggest potential associations of
elevated circulating IL-6, a measure known to predict CVD and
diabetes, with biological ageing, observations which require
further study to tease out potential mechanistic links.
Materials and Methods
Ethics Statement
The study was approved by the Glasgow Royal Infirmary
Research Ethics Committee and all participants gave written
informed consent.
Participants
The design of the psychological, social, and biological deter-
minants of ill health (pSoBid) study has been described elsewhere
[6]. In brief, participants were ranked on the basis of multiple
deprivation indicators to define the least and most deprived areas
in the NHS Greater Glasgow Health Board area, using criteria
established in the Scottish Index for Multiple Deprivation (SIMD).
Sampling was stratified to achieve an approximately equal
distribution of the 666 participants across males and females and
age groups (35–44, 45–54 and 55–64 years) within the most
(bottom 5% of SIMD score) and least deprived areas (top 20% of
SIMD score). Participants undertook a physical examination
(including measurement of blood pressure, body mass index (BMI),
and waist hip ratio (WHR)) and lifestyle questionnaires as detailed
previously [6]. A total of 382 blood samples were available for
telomere analysis.
Analytical parameters
Measurement of biochemical parameters have been described
in detail elsewhere [5]. In brief, cholesterol and triglyceride
concentrations were determined by enzymatic colorimetric assays
on a Roche Hitachi 917 analyser (Roche Diagnostics Ltd, Burgess
Hill, UK). Lipid fractions were measured using ultracentrifugation
and precipitation methods. Glucose was measured by hexokinase
and glucose-6-phosphate dehydrogenase assay on an Abbott
c8000 analyser (Abbott Diagnostics, Maidenhead, UK). Insulin
was measured by ELISA (Mercodia AB, Uppsala, Sweden and
ALPCO Diagnostics, Salem, NH, USA, respectively). C-reactive
protein levels were determined by an immunoturbidimetric assay
(Roche Diagnostics Ltd). High sensitivty interleukin-6, von Will-
ebrand factor and intercellular adhesion molecule 1 were
Table 2. Highlights the percentage change in biomarker
levels that is associated with an increase in telomere length.
Outcome
Percentage Change (95% CI)
p-Value
Systolic BP (mmHg) 0.2 (21.1, 1.5) p=0.798
Diastolic BP (mmHg) 0.3 (21.0, 1.7) p=0.642
Cholesterol (mmol/l) 2.4 (0.3, 4.6) p=0.027
HDL cholesterol (mmol/l) 21.2 (23.9, 1.6) p=0.387
LDL cholesterol (mmol/l) 3.7 (0.4, 7.1) p=0.027
Triglycerides (mmol/l) 2.7 (22.6, 8.3) p=0.326
Glucose (mmol/l) 0.8 (21.0, 2.7) p=0.363
Insulin (mU/l) 20.5 (27.5, 6.9) p=0.884
HOMA - IR 20.1 (27.5, 8.0) p=0.989
C reactive protein (mg/l) 0.6 (29.9, 12.4) p=0.916
Interleukin 6 (pg/ml) 27.2 (212.9, 21.1) p=0.022
Intercellular adhesion molecule 1 (ng/ml) 20.3 (22.9, 2.3) p=0.796
Fibrinogen (g/l) 0.2 (21.9, 2.4) p=0.829
von Willebrand factor (IU/dl) 21.2 (24.2, 1.8) p=0.416
D-dimer (ng/ml) 21.7 (27.4, 4.4) p=0.583
Individuals with longer telomeres had increased levels of total cholesterol (2.4%
increase, p=0.027) and LDL cholesterol (3.7%, p=0.027). Conversely, shorter
telomeres were associated with increased levels of IL-6 (7.2% decrease,
p=0.022). All analyses were adjusted for age, gender and deprivation group.
The change in telomere length was measured by an increase of one standard
deviation in log telomere length.
doi:10.1371/journal.pone.0022521.t002
Table 3. Highlights the percentage change in IL6 levels that
is associated with an increase in telomere length.
Adjustment covariates % Change in IL6 Levels (95% CI)
None 29.9 (216.3, 23.0), p=0.006
Age + gender 27.0 (213.6, 0.1), p=0.052
… + current smoking 25.9 (212.4, 1.0), p=0.094
… + deprivation group 25.7 (211.9, 0.9), p=0.090
… + income $/, £25,000 25.6 (211.8, 1.0), p=0.093
… + diet score $/, median 25.6 (211.8, 1.0), p=0.096
This analysis was adjusted for the various different SES and lifestyle factors to
determine their contribution to the difference in IL6 levels. The change in
telomere length was measured by an increase of one standard deviation in log
telomere length.
doi:10.1371/journal.pone.0022521.t003
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and DAKO UK Ltd, Ely, UK). Fibrinogen was measured on an
automated coagulometer (MDA-180; Organon Teknika, Cam-
bridge, UK). D-dimer was measured by ELISA (Hyphen,
Neuville-sur-Oise, France).
Indices of dietary intake
A diet score for the consumption of fruit and vegetables was
calculated from subjects self-reported food frequency question-
naire responses. Participants were asked on average how often
they consumed a range of food categories (21 food categories
listed). Responses for each question ranged from daily consump-
tion (number of portions per day) to weekly and monthly con-
sumption. Participants selected one response per food category.
For the purposes of the present analysis, responses to four
questions from the food frequency questionnaire relating to fruit
and vegetable intake were aggregated to give an overall indicative
diet score (i.e. frequency of intake of fresh fruit, cooked green
vegetables (fresh or frozen), cooked root vegetables (fresh or frozen)
and raw vegetables or salad (including tomatoes)). Monthly diet
scores were calculated on the basis of a 28 day month. The
maximum possible total diet score was 672 (6 portions per day x
28 days per month x 4 food category questions).
Telomere length determination
DNA was extracted from PBLs following standard procedures
and telomere lengths in the DNA samples were determined by Q-
PCR, following the method of Cawthon [44] as described
previously [11,33]. Telomere length determination was performed
using a Roche Light Cycler LC480. Telomere length analyses
were performed in triplicate for each sample, using a single-copy
gene amplicon primer set (acidic ribosomal phosphoprotein, 36B4)
and a telomere-specific amplicon primer set [7]. Quality control
parameters employed for the amplifications comprised using a cut
off 0.15 for the standard deviation (SD) of the threshold cycle (Ct)
for sample replicates. At a SD above 0.15 the sample was rea-
nalysed. The average SD across plates was 0.05.
Relative telomere length was estimated from Ct scores using the
comparative Ct method after confirming that the telomere and
control gene assays yielded similar amplification efficiencies. This
method determines the ratio of telomere repeat copy number to
single copy gene number (T/S) ratio in experimental samples
relative to a control sample DNA. This normalised T/S ratio was
used as the estimate of relative telomere length (Relative T/S).
The inter-assay variation was assessed by comparing the relative
telomere estimates (T/S ratio) across assays for the positive
controls, which were assayed on every assay plate. The average
inter-assay coefficient of variance was 0.3% for telomere and 0.1%
for 36B4 plates.
Statistical analyses
Associations between telomere length and participant charac-
teristics were investigated in linear regression models. Sampling
was stratified by age, gender and deprivation group, and all
models were adjusted for these factors. Because telomeres are
expected to shorten gradually with age, age was represented in
models as a continuous rather than categorical covariate.
When investigating factors that might influence ageing such as
SES and lifestyle, telomere length was modelled as an outcome.
Biomarkers, on the other hand, may be viewed as downstream of
ageing, motivating their modelling as outcomes with telomere
length as a covariate.
Telomere length and biomarkers were log-transformed for
regression analysis to satisfy the assumption of normally distributed
residuals. Regression coefficient estimates were therefore multipli-
cative when transformed back to the original scale. For example, a
regression coefficient for a binary characteristic back-transormed
to 1.1 implies the characteristic is associated with a 10% difference
in the outcome. Thus, where log telomere length was the outcome,
regression coefficients are presented as the percentage change in
telomere length associated with each patient characteristic. Where
telomere length was a covariate, a telomere length z-score was
used so that the back-transformed regression coefficients could be
interpreted as the percentage change in biomarker level associated
with a one standard deviation increase in telomere length. The
telomere length z-score was calculated by standardising log telo-
mere length to have a mean of zero and standard deviation of one.
We hypothesised that the effects of telomere-shortening factors
accumulate over time, therefore the largest differences between
exposed and unexposed participants would be expected among the
oldest participants. We investigated this hypothesis by testing for
interactions between participant characteristics and age.
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